Helping to share the web since 1996
Jerry Carter
@RecombinantAntibody
1631619792
Creative Biolabs offers customized library construction services by means of various phage display systems. https://www.creative-biolabs.com/phage-display-library-construction.html
View Review Page →
Creative Biolabs offers its worldwide clients the best antibody screening services through its excellent biopanning strategies and state-of-the-art equipment. https://www.creative-biolabs.com/phage-display-library-construction.html
View Review Page →
Parsatuzumab is a humanized monoclonal antibody designed for the treatment of cancers, especially the solid tumors. It acts as an immunomodulator and binds to EGFL7.
View Review Page →Odulimomab is an investigational drug for the prevention of transplant rejection and for the treatment of various immunological diseases.
View Review Page →Icrucumab is a human monoclonal antibody designed for the treatment of solid tumors.
View Review Page →Fezakinumab is a human monoclonal antibody against interleukin-22, designed for the treatment of psoriasis and rheumatoid arthritis.
View Review Page →Enfortumab vedotin is a recombinant human antibody to Human PVRL4. It's being developed for the treatment of solid tumors.
View Review Page →Creative Biolabs develops and commercializes a full range of innovative integrated services based on phage display technologies. https://www.creative-biolabs.com/Phage-Display-Platform.html
View Review Page →
Elsilimomab (also known as B-E8) is a mouse monoclonal antibody and an immunosuppressive drug. It (OPR-003) targets (and blocks) Interleukin-6. It has undergone a number of early stage clinical trails, e.g. for lymphoma and myeloma.
View Review Page →Eldelumab is a monoclonal antibody designed for the treatment of Crohn's disease and ulcerative colitis.
View Review Page →Creative Biolabs has devoted itself to the development and application of scFv phage display technology. https://www.creative-biolabs.com/phage-display-service.html
View Review Page →
Briakinumab is a human monoclonal antibody developed for the treatment of rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis.
View Review Page →Ganitumab is a human monoclonal antibody against type 1 insulin-like growth factor receptor (IGF1R), designed for the treatment of cancers.
View Review Page →Vanucizumab is a recombinant Humanized antibody to Human VEGFA. It is under research to treat solid tumors.
View Review Page →Tabalumab is an anti-B-cell activating factor (BAFF) human monoclonal antibody designed for the treatment of autoimmune diseases and B cell malignancies.
View Review Page →
